Samantha is a partner in Gowling WLG’s Corporate Group and is head of the firm’s UK Cannabis Group. She specialises in corporate finance, mergers and acquisitions and equity capital markets.
With extensive experience of acting for companies, or their advisers, on IPOs and secondary transactions, Samantha regularly advises on a range of domestic and cross border M&A transactions, including public takeovers. She also has significant experience in a range of sectors including retail and consumer, life sciences, healthcare, and natural resources.
Gowling WLG works closely with a number of leading cannabis companies, and businesses that support them, providing expertise across a range of practice areas including corporate finance and public listings, M&A, intellectual property, tax, real estate, advertising, marketing, labelling, licencing, product liability and regulatory. Samantha’s clients include investment banks, financial advisors and brokers, as well as start-ups seeking initial investment, through to listed companies with multi-million market capitalisations focusing on a range of activities including medicinal cannabis, cultivation and extraction, CBD and wellness, cosmetics, data sharing and novel foods.
Samantha’s career history includes a secondment to the Corporate Finance team of Singer Capital Markets. She also co-authored the AIM chapter in ‘World Stock Exchanges – A Practical Guide’, having over ten years’ experience advising AIM listed clients, and contributed to the English law report in the World Law Group’s 2020 Global Report on Cannabis Policy. Samantha is a vice president on the board of the Canada UK Chamber of Commerce.
- Insights & Resources
- News and Press Releases
- World Law Group: 2020 Global Report on Cannabis Policy
- Emyria: myriad data – individual care (‘London is open for medical Cannabis listing’ – Pages 14-15)
Recent Published Deals
- Gowling WLG advises on the first LSE listing of a medicinal-cannabis company
- Gowling WLG advises Britannia Bud Canada holdings Inc. On its strategic partnership with a UK laboratory